Skip to main content
. 2014 Aug 11;7:1415–1422. doi: 10.2147/OTT.S64559

Figure 3.

Figure 3

(A) The PFS of patients without bevacizumab, in the high and low serum LDH level groups; (B) the PFS of patients with bevacizumab, in the high and low serum LDH level groups.

Abbreviations: LDH, lactate dehydrogenase; PFS, progression-free survival.